Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
1699.0000 -1.10 (-0.06%)
NSE Jul 22, 2026 15:31 PM
Volume: 181.6K
 

logo
Dr. Lal Pathlabs Ltd.
13 Apr 2026
1699.00
-0.06%
buy
by FundsIndia
Target: 1644 | Target met
FundsIndia
Volume-Led Growth. Patient volumes recovering steadily. Expansion in Tier 2/3/4 markets. Increased tests per patient.
 
Number of FII/FPI investors increased from 351 to 357 in Jun 2026 qtr.
More from Dr. Lal Pathlabs Ltd.
Recommended
Which stocks did superstar investors buy in Q1FY27?
The Baseline | 22 Jul 2026, 05:59PM
Market closes lower on weakness in pharma, banking and oil-sensitive stocks
Trendlyne Marketwatch | 22 Jul 2026, 04:00PM
Dr Lal Pathlabs - Flat quarter but expanding pan India presence
| 21 Mar 2022, 12:21PM